Busulfan April 12, 2017 Busulfan Trade Name Spartaject Orphan Indication Primary brain malignancies USA Market Approval USA USA Designation Date 1997-07-07 00:00:00 Sponsor SuperGen, Inc.;Two Annabel Lane, Suite 220;San Ramon, California, 94583
